TAMPA, Fla., Nov. 15, 2004 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), one of the nation's leading sources of affordable prescription medications, has signed a distribution agreement to provide LabPass Solutions Corp. access to Rx Processing's affordable mail-order prescription medications. LabPass Solutions is a Florida-based drug screening administrator and leading diagnostic lab testing provider that services hundreds of small to midsize American companies including independent truckers associations.
This agreement establishes Rx Processing Corporation as the new mail-order prescription-processing center for LabPass Solutions for the next two years. Rx Processing works with licensed pharmacies both domestically and internationally, to provide top-quality lower-cost name brand and generic drugs to consumers. A cost savings of up to 84% is realized by filling prescriptions with either discounted U.S. or Canadian government-approved drugs.
According to LabPass Solutions President Peter Matuch, "Our mission to provide affordable diagnostic lab tests in today's sky rocketing healthcare setting is being complemented by Rx Processing's low-cost prescription drugs. Affordable lab tests save our members lives through early detection and prescription drugs provide our members treatment options."
"American companies now have access to vital prescription drug benefits for their employees without sacrificing safety or quality," says Peter Fiorillo, president of Rx Processing. "With affiliates like LabPass Solutions, Americans will clearly reduce their costs for healthcare services. This savings is critical for the millions of American corporations that lack access to diagnostic testing and prescription drug coverage."
More information on Lab Pass Solutions diagnostic lab screening tests is available at www.labpass.com.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.